Table GHK. Antibiogram for common bacterial isolates, Gleneagles Hospital Hong Kong, 2020
- Only the first isolates of a given species per patient per calendar year were inculded, irrespective of body site, antimicrobial susceptibility profile or other phenotypical characteristics.
- Results obtained from surveillance studies (MRSA Screening, CPE Screening, VRE Screening and GBS Screening) were excluded.
- Susceptibility results were interpreted according to 2020 CLSI definition except Cefoperazone-sulbactam (Sulperazon). Nonsusceptible included both intermediate and resistant.
- Overall prevalance of extended-spectrum beta-lactamases (ESBL) were 11% for Klebsiella species, 20% for E. coli. ESBL-producing strains should be interpreted as resistant to all penicillins, cephalosporins and aztreonam.
- In Streptococcus pneumoniae, resistance to azithromycin & clarithromycin can be predicted by testing erythromycin (CLSI M100).
- According to breakpoint for parenteral cefuroxime sodium.
- Results obtained from urine isolates only.
- Results obtained from non urine isolates only.
For Streptococcus pneumoniae, Penicillin (parenteral) MIC ≤0.06 µg/mL (53.1%), MIC 0.09-1µg/mL (34.4%), MIC 1.5-2 µg/mL (12.5%).
% Penicillin (parenteral) sensitive: non-meningitis breakpoint at MIC ≤2 µg/mL = 100% and meningitis breakpoint at MIC ≤0.06 µg/mL 53%.
# The annual number of isolates is small. Data from 2019 and 2020 were conbined in the calculation.
Indicate 10% or more reduction in resistant rate compared to 2019 figures.